Catalyst Wire Dossier Catalyst Wire Dossier

Acetyllevocarnitine hydrochloride tablets

acetyllevocarnitine hydrochloride · Haisco Pharmaceutical Group Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Acetyllevocarnitine hydrochloride tablets, covering 2022-04-08 to 2022-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN [Phase 3]

See pricing